BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 28, 2002
View Archived Issues
Celltech receives CDP-870 phase III milestone payment from Pharmacia
Read More
Embosphere Microspheres approved for treatment of uterine fibroid
Read More
PCL-016 enters phase IIa in acne
Read More
GenVec initiates phase I trial of AdPEDF in AMD
Read More
eXegenics and IDDS terminate merger agreement
Read More
Abbott and MerLion collaborate on natural product-based drug discovery
Read More
Photogen to acquire medical imaging assets from Alliance
Read More
Gruenenthal presents novel siderophores for delivering antibacterial agents
Read More
Phosphodiesterase inhibitors discovered at Ortho-McNeil
Read More
Bayer researchers present novel anticytomegalovirus agents
Read More
New ciclosporin prodrugs with utility in ocular disorders
Read More
Two series of TNF-alpha production inhibitors identified at Sanofi-Synthelabo
Read More
Gemin X's Bcl-2 inhibitors are effective proapoptotic and antitumor compounds
Read More
New nonanticoagulant heparin derivatives retain antiangiogenic/antitumor activity
Read More
CJ-13610: design of an orally active and safe 5-LO inhibitor
Read More
Long-acting, oral DPP-IV inhibitor and hypoglycemic agent presented in Shizuoka
Read More
Effective agents for nephritis without cardiovascular side effects designed at Tanabe Seiyaku
Read More
Potent anti-HIV agents targeting viral protease designed by U.S./Japanese team
Read More
Novartis files marketing applications for Prexige
Read More
NDA for palonosetron accepted for filing by the FDA
Read More
Lilly receives FDA approval for Strattera
Read More
Teriparatide approved by the FDA to treat osteoporosis
Read More
